Add Glucokinase Activator to Target A1c
Public ClinicalTrials.gov record NCT02405260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Adaptive Phase 2, Randomized, Double-Blind, Placebo- and Active-Controlled (Sitagliptin), Parallel Group Study to Evaluate the Safety and Efficacy of TTP399 Following 6 Months Administration in Subjects With Type 2 Diabetes Mellitus on A Stable Dose of Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is a multi-center, adaptive, randomized, double-blind, placebo- and active- controlled, parallel group, Phase 2 study in subjects with T2DM to evaluate the effect of TTP399 on HbA1c following administration for 6 months.
Study identification
- NCT ID
- NCT02405260
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 190 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2015 (Type not available)
- Primary completion
- Jul 2016 (Actual)
- Completion
- Sep 2016 (Actual)
- Last update posted
- Feb 10, 2017
2015 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mesa | Arizona | 85213 | — |
| Not listed | Tuscon | Arizona | 85741 | — |
| Not listed | Canoga Park | California | 91303 | — |
| Not listed | Huntington Park | California | 90255 | — |
| Not listed | Los Angeles | California | 90056 | — |
| Not listed | West Hills | California | 91307 | — |
| Not listed | Centennial | Colorado | 80112 | — |
| Not listed | Littleton | Colorado | 80127 | — |
| Not listed | Waterbury | Connecticut | 06708 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | Gurnee | Illinois | 60031 | — |
| Not listed | Evansville | Indiana | 47725 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | Greensboro | North Carolina | 27408 | — |
| Not listed | Moncks Corner | South Carolina | 29461 | — |
| Not listed | San Antonio | Texas | 78209 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Schertz | Texas | 78154 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02405260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2017 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02405260 live on ClinicalTrials.gov.